377 related articles for article (PubMed ID: 34453645)
1. Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.
Mitra T; Elangovan S
Mol Cell Biochem; 2021 Dec; 476(12):4363-4385. PubMed ID: 34453645
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
[TBL] [Abstract][Full Text] [Related]
3. Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review).
Jiménez-Wences H; Peralta-Zaragoza O; Fernández-Tilapa G
Oncol Rep; 2014 Jun; 31(6):2467-76. PubMed ID: 24737381
[TBL] [Abstract][Full Text] [Related]
4. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
6. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
[TBL] [Abstract][Full Text] [Related]
7. HDAC6 suppresses microRNA-199a transcription and augments HPV-positive cervical cancer progression through Wnt5a upregulation.
Shao Y; Zhu F; Zhu S; Bai L
Int J Biochem Cell Biol; 2021 Jul; 136():106000. PubMed ID: 33933678
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.
Sadri Nahand J; Moghoofei M; Salmaninejad A; Bahmanpour Z; Karimzadeh M; Nasiri M; Mirzaei HR; Pourhanifeh MH; Bokharaei-Salim F; Mirzaei H; Hamblin MR
Int J Cancer; 2020 Jan; 146(2):305-320. PubMed ID: 31566705
[TBL] [Abstract][Full Text] [Related]
10. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
11. ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women.
Isakova J; Vinnikov D; Bukuev N; Talaibekova E; Aldasheva N
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1057-1062. PubMed ID: 31030474
[TBL] [Abstract][Full Text] [Related]
12. Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.
Li J; Liu Q; Clark LH; Qiu H; Bae-Jump VL; Zhou C
Future Oncol; 2017 Apr; 13(8):743-753. PubMed ID: 27806630
[TBL] [Abstract][Full Text] [Related]
13. miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay.
Doghish AS; Ali MA; Elyan SS; Elrebehy MA; Mohamed HH; Mansour RM; Elgohary A; Ghanem A; Faraag AHI; Abdelmaksoud NM; Moustafa HAM
Pathol Res Pract; 2023 Apr; 244():154386. PubMed ID: 36868096
[TBL] [Abstract][Full Text] [Related]
14. Understanding the HPV integration and its progression to cervical cancer.
Oyervides-Muñoz MA; Pérez-Maya AA; Rodríguez-Gutiérrez HF; Gómez-Macias GS; Fajardo-Ramírez OR; Treviño V; Barrera-Saldaña HA; Garza-Rodríguez ML
Infect Genet Evol; 2018 Jul; 61():134-144. PubMed ID: 29518579
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
16. Cellular redox, cancer and human papillomavirus.
Cruz-Gregorio A; Manzo-Merino J; Lizano M
Virus Res; 2018 Feb; 246():35-45. PubMed ID: 29337161
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus, MicroRNA and their Role in Cervical Cancer Progression, Diagnosis and Treatment Response: A Comprehensive Review.
Jamal A; Shahid I; Naveed Shahid M; Saleh Alshmemri M; Saeed Bahwerth F
Pak J Biol Sci; 2020 Jan; 23(8):977-988. PubMed ID: 32700847
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.
Pedroza-Torres A; López-Urrutia E; García-Castillo V; Jacobo-Herrera N; Herrera LA; Peralta-Zaragoza O; López-Camarillo C; De Leon DC; Fernández-Retana J; Cerna-Cortés JF; Pérez-Plasencia C
Molecules; 2014 May; 19(5):6263-81. PubMed ID: 24840898
[TBL] [Abstract][Full Text] [Related]
20. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
